PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1782011
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1782011
Thyroid function testing market size was valued at US$ 4,940.22 Million in 2024, expanding at a CAGR of 6.60% from 2025 to 2032.
The thyroid function testing market includes the worldwide industry that develops, produces, distributes, and uses diagnostic tests to evaluate how well the thyroid gland works. These tests mainly measure levels of thyroid hormones, such as Thyroxine (T4), Triiodothyronine (T3), and Thyroid-Stimulating Hormone (TSH). They help diagnose and monitor thyroid disorders like hypothyroidism, hyperthyroidism, thyroid cancer, and autoimmune thyroid diseases.
This market includes a range of testing modalities such as immunoassays, blood tests, imaging, and molecular diagnostics. It serves various end users including hospitals, diagnostic laboratories, research institutions, and point of care testing centers. The market is driven by increasing prevalence of thyroid disorders, growing awareness about thyroid health, advancements in diagnostic technologies, and rising healthcare expenditure globally.
Thyroid Function Testing Market- Market Dynamics
Expanding Healthcare Infrastructure Improves Access to Diagnostics
The global effort to improve healthcare infrastructure has been vital for increasing access to diagnostic tests, including thyroid function testing. Investments in new healthcare facilities, upgrading lab equipment, and training healthcare professionals are essential for making thyroid diagnostics more available.
According to the World Health Organization (WHO), about 47% of people around the world lack access to basic diagnostic services. This figure is slowly going down because of improvements in infrastructure, especially in low and middle-income countries. Better infrastructure allows for the use of modern diagnostic technologies like automated immunoassays. This leads to quicker and more accurate analysis of thyroid hormones.
In emerging markets such as India, China, and Brazil, governments have made healthcare expansion a key part of their national health plans. Such as, India's Ayushman Bharat program is changing primary healthcare by setting up thousands of Health and Wellness Centers, many of which can perform thyroid testing. This effort is expected to help over 500 million people gain access to diagnostics.
Overall, the expansion of healthcare infrastructure not only increases physical access to thyroid function testing but also enhances the quality and reliability of diagnostic services, driving market growth.
For Instance,
In August 2024, Siemens Healthineers launched the Atellica CI Analyzer at Mahajan Imaging & Labs in India. This advanced diagnostic system can analyze over 200 parameters across 20 different disease states, including thyroid function tests. Featuring microvolume technology, the analyzer enables accurate testing using small sample volumes, making it ideal for pediatric and critical care patients. Additionally, the device delivers rapid results, with critical tests completed in just 14 minutes, significantly enhancing diagnostic efficiency in thyroid function testing.
Thyroid Function Testing Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.60% over the forecast period (2025-2032)
Based on product segmentation, reagents & kits was predicted to show maximum market share in the year 2024
Based on test type segmentation, TSH Test was the leading test type in 2024
Based on sample type segmentation, Serum/Plasma was the leading sample type in 2024
Based on end user segmentation, hospitals was the leading end user in 2024
On the basis of region, North America was the leading revenue generator in 2024
The global thyroid function testing market is segmented on the basis of product, test type, sample type, end user, and region.
The market is divided into three categories based on product: instruments, reagents & kits, and other products. The reagents & kits sector dominates the market due to these consumables are essential for conducting thyroid hormone assays such as TSH, T3, and T4 tests. Unlike instruments, which are typically a one-time or infrequent purchase, reagents and kits require constant replenishment, driving steady demand. Laboratories, hospitals, and diagnostic centers regularly purchase these products to perform routine and large volumes of thyroid function tests, contributing significantly to the overall market revenue. Additionally, advancements in reagent formulations and kit sensitivity further boost this subsegment's growth.
The market is divided into five categories based on end user: clinics, diagnostic laboratories, hospitals, research laboratories & institutes and other end users. The hospitals sector dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to they provide comprehensive diagnostic services and handle a high volume of patients requiring thyroid disorder diagnosis and monitoring. Equipped with advanced laboratories and trained personnel, hospitals conduct a wide range of thyroid function tests, including emergency and inpatient testing, making them the primary consumers of thyroid diagnostic products and services.
Thyroid Function Testing Market- Geographical Insights
North America dominates the global thyroid function testing market during the forecast period in 2024.
North America dominates the thyroid function testing market. This is mainly due to its strong healthcare system and widespread use of modern diagnostic technologies. The U.S. especially benefits from significant healthcare funding, broad insurance coverage, and expanded screening programs for thyroid disorders. Additionally, the high rates of thyroid diseases, such as hypothyroidism and thyroid cancer, create a steady demand for thyroid function tests. Major global diagnostic companies like Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers have headquarters or substantial operations in this region, which further supports market growth. Moreover, growing awareness about thyroid health and preventive care enhances North America's position in this market.
Asia Pacific is estimated to register the highest CAGR in the thyroid function testing market during the forecast period in 2024.
The Asia-Pacific region is becoming the fastest-growing market for thyroid function testing due to several key factors. Rapid population growth and urbanization in countries like India, China, and Southeast Asia have increased the number of thyroid disorder cases. This is partly due to iodine deficiency and lifestyle changes. In addition, governments in the region are investing heavily to expand healthcare infrastructure and diagnostic capabilities. This investment is improving access to thyroid testing, even in rural and remote areas. Rising awareness among healthcare professionals and patients about the importance of early diagnosis and treatment of thyroid diseases is driving market growth. The growing affordability of diagnostic services and the introduction of cost-effective testing kits also make thyroid testing more accessible to a larger population.
The thyroid function testing market is very competitive, with major global players like Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, and bioMerieux. These companies focus on creating faster, more accurate, and user-friendly diagnostic kits and analyzers. They often use technologies like microvolume testing. Partnerships with hospitals, diagnostic chains, and governments help them reach a wider audience, especially in emerging areas like Asia-Pacific and Latin America. Expanding geographically through local partnerships and customized product offerings is a common way to grow. Additionally, buying smaller companies with innovative technologies helps strengthen their market presence. As the need for early and reliable thyroid disease diagnosis increases, companies that prioritize technology, affordability, and accessibility are likely to lead the market in the coming years.
In July 2024, Roche Diagnostics partnered with public hospitals in Brazil to expand access to their Cobas immunoassay systems. This collaboration aimed to improve thyroid disorder diagnosis by providing reliable testing across urban and rural healthcare centers. The partnership enhances Roche's market penetration in Latin America and drives adoption of its high-throughput diagnostic platforms.
In March 2024, Thermo Fisher Scientific acquired a diagnostics startup specializing in thyroid test kits. This acquisition expanded Thermo Fisher's portfolio, enabling broader availability of sensitive and cost-effective thyroid function testing solutions. It also accelerates the company's growth in the specialized diagnostics segment.
In January 2024, bioMerieux launched mobile immunoassay units in Latin America to provide thyroid function testing in remote and underserved areas. This innovation increased diagnostic accessibility and helped improve thyroid disorder management in rural communities, positioning bioMerieux as a key player in expanding healthcare access and driving regional market growth.
In September 2023, Neuberg Diagnostics completed merger of Supratech and Anand Reference Laboratory. This strategic move marks a significant milestone in enhancing healthcare services, as the combined entity strengthens Neuberg's commitment to providing superior diagnostics and improved patient care.